As Charles River And WuXi PharmaTech Count Down To Shareholder Votes On Proposed Merger, Research Analysts Predict Defeat
This article was originally published in The Pink Sheet Daily
Executive Summary
Charles River says the CRO's major pharma clients support the deal.